Hyvv

Startup

Hyvv is a clinical trial intelligence platform for sponsors.

In rare disease, your site list decides whether the trial recruits. Patients sit in a small number of centres, the same investigators appear on every competing study in the indication, and a country chosen on familiarity rather than evidence can cost a year of enrolment.

Hyvv gives sponsors an independent read on feasibility before that list is locked. Every country and site is scored against patient epidemiology, competing trial density, treatment landscape, site capability, investigator workload and regulatory environment, and returned as a protocol-specific report in days.

Independent feasibility intelligence, delivered before the decisions become expensive.



website

Get involved at World Orphan Drug Congress Europe 2026

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.